Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status

por Adachi, Yuichi, Tamiya, Akihiro, Taniguchi, Yoshihiko, Enomoto, Takatoshi, Azuma, Kouji, Kouno, Shunichi, Inagaki, Yuji, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Publicado 2019

Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report

por Inagaki, Yuji, Tamiya, Akihiro, Matsuda, Yoshinobu, Azuma, Kouji, Adachi, Yuichi, Enomoto, Takatoshi, Kouno, Shunichi, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Publicado 2020

Retrospective analysis of long‐term survival factors in patients with advanced non‐small cell lung cancer treated with nivolumab

por Murakami, Yusuke, Tamiya, Akihiro, Taniguchi, Yoshihiko, Adachi, Yuichi, Enomoto, Takatoshi, Azuma, Koji, Inagaki, Yuji, Kouno, Shunichi, Matsuda, Yoshinobu, Okishio, Kyoichi, Atagi, Shinji
Publicado 2022

Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease

por Okano, Naoko, Kubo, Nobuteru, Yamaguchi, Koichi, Kouno, Shunichi, Miyasaka, Yuhei, Mizukami, Tatsuji, Shirai, Katsuyuki, Saitoh, Jun-ichi, Ebara, Takeshi, Kawamura, Hidemasa, Maeno, Toshitaka, Ohno, Tatsuya
Publicado 2021

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

por Takehara, Kazutaka, Koga, Yasuhiko, Hachisu, Yoshimasa, Utsugi, Mitsuyoshi, Sawada, Yuri, Saito, Yasuyuki, Yoshimi, Seishi, Yatomi, Masakiyo, Shin, Yuki, Wakamatsu, Ikuo, Umetsu, Kazue, Kouno, Shunichi, Nakagawa, Junichi, Sunaga, Noriaki, Maeno, Toshitaka, Hisada, Takeshi
Publicado 2022